Warpaint London (LON: W7L) is bidding 48p/share in cash for Brand Architekts (LON: BAR), valuing the company at £13.9m. There is a share alternative. Warpaint London believes that its relationships with retailers will help to boost sales of the health and beauty brands, such as Skinny Tan and Super Facialist, owned by Brand Architekts, which has high overheads compared with its revenues. The acquisition should be earnings enhancing in 2025. Brand Architekts shares jumped 91.7% to 46p. Warpaint London shares increased 3.05% to 540p.
Quadrise (LON: QED) released positive engine testing results on new prototypes of bioMSAR fuel, including a 100% biofuel. It showed an 85% reduction in carbon dioxide emissions compared to marine fuels and a significant reduction compared with diesel. This means that it could achieve a commercial, entirely fossil-free fuel before 2030. The share price rose a further 21.4% to 4.15p.
Sunrise Resources (LON: SRES) says that the CS pozzolan project in Nevada is mine-ready with an expected cement market customer base in California. There is currently funding discussion with four separate groups. The share price improved 15.4% to 0.0375p.
Pharma modelling company Physiomics (LON: PYC) has won a £157,000 with a long-standing client for assessing dosing and scheduling for a cancer treatment combination. The project will take less than 12 months. The share price is 11.5% higher at 0.725p.
FALLERS
Interim figures from telematics supplier Trakm8 (LON: TRAK) show reduced revenues from £8.54m to £8.31m, following a reduction in recurring revenues from £5.23m to £4.51m. The pre-tax profit slumped from £119,000 to £15,000. Net debt was £6.66m at the end of September 2024. Full year expectations have been reduced. The insurance market remains tough. There could be some improvement next year, but the outlook is uncertain. The share price slumped 21.7% to 4.5p.
Media analysis provider Ebiquity (LON: EBQ) has done better in the second half but not as well as it hoped. Some of the expected revenues will be delayed until next year. This will lead to a £2.6m shortfall in revenues that falls down to profit. Pre-tax profit will fall from £9.7m to £6.1m, compared with the £8.4m previously expected. Next year’s pre-tax profit forecast has been cut from £10.5m to £7.3m. The share price declined 17.8% to 18.5p.
Scancell Holdings (LON: SCLP) has taken advantage of the share price rise on the back of Geomab exercising its option to licence an anti-glycan monoclonal antibody from the company. The total deal is worth up to $630m and the upfront payment could be around $5m. Scancell was expected to have enough cash until the end of 2025, so the £10.3m fundraising at 10.5p/share will lengthen the time the cash will last. A retail offer could raise up to £1m. The share price slipped 17.6% to 11.125p.
Serica Energy (LON: SQZ) says that there has been another problem with the Trion FPSO in the North Sea, which has led to suspension of production. There is an issue with a compressor seal. Full repairs will not be completed until next year. Production for 2024 is forecast to be approximately 35,000-36,000 barrels of oil equivalent/day. The share price dipped 5.56% to 123.9p.
EMV Capital (LON: EMVC) raised £567,000 from its retail offer at 50p/share and an additional subscription means that a total of £1.5m was raised. The share price fell 2.88% to 50.5p.
Ex-dividends
Croma Security Solutions Group (LON: CSSG) is paying a final dividend of 2.3p/share and the share price fell 1.5p to 89p.
Mercia Asset Management (LON: MERC) is paying an interim dividend of 0.37p/share and the share price declined 0.4p to 30p.
Supreme (LON: SUP) is paying an interim dividend of 1.8p/share and the share price slipped 3.5p to 169p.